<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2024.1481656</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Terpenoids as principal bioactive compound of <italic>Cissampelos oppositifolia</italic> essential oils: enhancing synergistic efficacy with conventional antibiotics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Kexin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Yurong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dev</surname>
<given-names>Kamal</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" corresp="yes">
<name>
<surname>Sharma</surname>
<given-names>Vipasha</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2091534"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" corresp="yes">
<name>
<surname>Pang</surname>
<given-names>Xinli</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2632601"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Respiratory Medicine, Shenzhen Children&#x2019;s Hospital</institution>, <addr-line>Shenzhen, Guangdong</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Shenzhen People&#x2019;s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology).</institution>, <addr-line>Shenzhen, Guangdong</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pharmacology and Toxicology, Wright State University</institution>, <addr-line>Dayton, OH</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>University Institute of Biotechnology, Chandigarh University</institution>, <addr-line>Mohali</addr-line>, <country>India</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Sanjit Kumar, Guru Ghasidas Vishwavidyalaya, India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Prakash Shukla, VIT University, India</p>
<p>Afreen Anjum, Guru Ghasidas University, India</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xinli Pang, <email xlink:href="mailto:Pangxinli2024@163.com">Pangxinli2024@163.com</email>; Vipasha Sharma, <email xlink:href="mailto:sharma.vipasha@gmail.com">sharma.vipasha@gmail.com</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
<fn fn-type="equal" id="fn004">
<p>&#x2021;These authors have contributed equally to this work and share last authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>11</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1481656</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>10</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Zhao, Jiang, Dev, He, Sharma and Pang</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhao, Jiang, Dev, He, Sharma and Pang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>The rise of antibiotic resistance imposes the search for novel antimicrobial strategies as natural products or its combination with antibiotics. This study investigates the synergistic effects of terpenoids from <italic>Cissampelos oppositifolia</italic> (<italic>C. oppositifolia</italic>) essential oil in combination with antibiotics against <italic>Escherichia coli</italic> (<italic>E. coli</italic>) and <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>). The aims were to evaluate the antimicrobial efficacy, analyze functional group modifications and assess molecular interaction.</p>
</sec>
<sec>
<title>Methods</title>
<p>Essential oil was extracted from <italic>C. oppositifolia</italic> by hydro-distillation. The EO was analyzed for terpenoid content via Thin Layer Chromatography (TLC). Antimicrobial activity was assessed using the disc diffusion method and Minimum Inhibitory Concentration determinations (MIC) by broth dilution followed by bactericidal essay (Time-killing). FTIR and UV spectroscopy were employed to detect functional group modifications in terpenoid-antibiotic combinations. Molecular docking studies assessed interaction energies between terpenoids and antibiotics.</p>
</sec>
<sec>
<title>Results</title>
<p>TLC identified &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene in the EO. &#x3b4;-Carene exhibited the highest synergy with antibiotics, showing the lowest MIC of 0.04 mg/mL against <italic>S. aureus</italic> ATCC-43300 and 0.05 mg/mL against <italic>E. coli</italic> MTCC-739. Time-kill assays demonstrated that &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene achieved complete bacterial eradication by 4 hours in combination with amoxicillin against <italic>E. coli</italic>, and by 2 hours against <italic>S. aureus</italic> in combination with erythromycin. FTIR analysis revealed peak shifts at 1599, 1774, and 2259 cm<sup>&#x2212;1</sup> for amoxicillin + &#x3b1;-pinene, and new peaks at 1648 and 1287 cm<sup>&#x2212;1</sup> for &#x3b4;-carene + erythromycin. UV spectra indicated potential complex formations. Docking studies showed &#x3b4;-carene&#x2019;s strong interaction with erythromycin and amoxicillin, with interaction energies of -96.10 and -87.75 kcal/mol, respectively.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Terpenoids from <italic>C. oppositifolia</italic> enhance the antimicrobial efficacy of antibiotics. Functional group modifications and complex formations suggest that these interactions may contribute to synergistic effects. These findings support the potential use of terpenoid-antibiotic combinations in overcoming antibiotic resistance and warrant further investigation into their mechanisms of action.</p>
</sec>
</abstract>
<kwd-group>
<kwd>terpenoids</kwd>
<kwd>antibiotics</kwd>
<kwd>synergy</kwd>
<kwd>spectroscopy</kwd>
<kwd>docking studies</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="37"/>
<page-count count="11"/>
<word-count count="5089"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Antibiotic Resistance and New Antimicrobial drugs</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The global incidence of microbial infectious diseases is rising (<xref ref-type="bibr" rid="B26">Masyita et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B31">Salvi et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B5">Baker et&#xa0;al., 2022</xref>), significantly impacted by the increasing prevalence of microbial drug resistance to current antimicrobial agents (<xref ref-type="bibr" rid="B30">Salam et&#xa0;al., 2023</xref>). This resistance results in multidrug-resistant microbes causing widespread infections. This is linked to higher morbidity and mortality rates of about 4.95 million people who died by drug-resistant infections among 1.27 million deaths by antibiotic resistance in 2019 (<xref ref-type="bibr" rid="B3">Antimicrobial Resistance Collaborators, 2022</xref>). The growing issue of antibiotic resistance and the higher recurrence rates of common infections are straining healthcare systems and societies (<xref ref-type="bibr" rid="B2">Ali et&#xa0;al., 2024</xref>). Predictions indicate that by 2050, the mortality attributable to antimicrobial resistance may exceed 10 million annually, surpassing that of other major diseases and cancers (<xref ref-type="bibr" rid="B11">de Kraker et&#xa0;al., 2016</xref>). Consequently, there is an urgent need for novel antimicrobial agents or the use of a combination of natural remedies with modern antibiotics to treat MDR infections (<xref ref-type="bibr" rid="B22">Konwar et&#xa0;al., 2022</xref>). Natural products, particularly those derived from plants, offer a promising avenue for discovering new antimicrobial agents (<xref ref-type="bibr" rid="B9">Cowan, 1999</xref>). Medicinal plants have been used throughout history for their therapeutic properties, with essential oils (EOs) being one of the most prominent natural products and so catching the attention of researchers globally (<xref ref-type="bibr" rid="B27">Nasim et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B7">Chaachouay and Zidane, 2024</xref>). EOs are concentrated hydrophobic liquids derived from plants, known as rich sources of bioactive compounds with antimicrobial, antiviral, antioxidant, anti-inflammatory, and other pharmacological effects. Plants produce these chemicals to protect themselves, contributing to their color, aroma, and flavor. Essential oils, as key secondary metabolites, are responsible for many of these pharmaceutical properties (<xref ref-type="bibr" rid="B26">Masyita et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B31">Salvi et&#xa0;al., 2022</xref>). EOs are found in the cytoplasm of specific plant cell secretions in various plant organs, including secretory hairs or trichomes, epidermal cells, internal secretory cells, and secretory pockets (<xref ref-type="bibr" rid="B14">Gersbach, 2002</xref>). These oils are complex mixtures that may contain over 300 different compounds. They consist of organic volatile compounds, generally of low molecular weight below 300 g/mol (<xref ref-type="bibr" rid="B13">Dhifi et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B12">de Sousa et&#xa0;al., 2023</xref>). These Eos consistent compounds belong to various chemical classes: alcohols, ethers or oxides, aldehydes, ketones, esters, amines, amides, phenols, heterocycles, and mainly the terpenes. Alcohols, aldehydes, and ketones offer a wide variety of aromatic notes, such as fruity ((E)-nerolidol), floral (Linalool), citrus (Limonene), herbal (&#x3b3;-selinene), etc. Among all chemical components of EOs, terpenes and terpenoids have been comprehensively studied and reported to play key roles in human health (<xref ref-type="bibr" rid="B21">Jugreet et al., 2020</xref>; <xref ref-type="bibr" rid="B18">Haro-Gonz&#xe1;lez et&#xa0;al., 2021</xref>). Terpenoids or terpenes are the most structurally varied classes and they are the largest family of compounds of plant products. Previous studies estimated the existence of more than 23,000 known terpenoid compounds, including monoterpenes, sesquiterpene, carotenoids, tetraterpenes, diterpenes, tocopherol, phytol, steroids and hormones (<xref ref-type="bibr" rid="B26">Masyita et&#xa0;al., 2022</xref>). The monoterpenes and sesquiterpene are the most dominant terpenoids present in the Eos. These compounds contribute to the flavor and aroma of plants but they have therapeutic potential (<xref ref-type="bibr" rid="B28">Proshkina et&#xa0;al., 2020</xref>). The monoterpenes and sesquiterpene oxygenated derivatives of terpenes are recognized for their ability to combat both antibiotic-susceptible and resistant bacteria. They act primarily by disrupting microbial cell membranes, inhibiting protein synthesis, and interfering with DNA replication (<xref ref-type="bibr" rid="B26">Masyita et&#xa0;al., 2022</xref>). Compounds such as carvacrol, carvone, eugenol, geraniol, and thymol have demonstrated antibacterial properties against pathogens including <italic>Staphylococcus aureus</italic>. <italic>C. oppositifolia</italic> is a traditional medicinal plant widely used in various cultures for its therapeutic properties. Known for its rich phytochemical profile, it contains essential oils abundant in terpenoids, particularly &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene, which are recognized for their antimicrobial, anti-inflammatory, and antioxidant activities (<xref ref-type="bibr" rid="B32">Shang et&#xa0;al., 2024</xref>). Historically, the plant has been employed in herbal medicine to treat ailments such as fevers, respiratory disorders, and infections (<xref ref-type="bibr" rid="B33">Sharma et&#xa0;al., 2021</xref>). Recent studies highlight its potential in modern medicine, especially in enhancing the efficacy of conventional antibiotics, making it a promising candidate for further research in phytotherapy and drug development (<xref ref-type="bibr" rid="B25">Mahizan et&#xa0;al., 2019</xref>). These terpenoids have shown potential in enhancing the effectiveness of conventional antibiotics through synergistic interactions. This study aims to investigate the principal bioactive terpenoids in the essential oils of <italic>C. oppositifolia</italic> and their role in improving antibiotic efficacy. By exploring these interactions, the research seeks to contribute to the development of more effective antimicrobial strategies and address the growing challenge of drug-resistant infections.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<p>The present study was conducted in accordance with the biosafety regulations of the university. <italic>Escherichia coli</italic> MTCC-739 and <italic>Staphylococcus aureus</italic> ATCC-43300 were obtained from the Institute of Microbial Technology (IMTECH), Chandigarh. The research was approved by the university&#x2019;s research committee.</p>
<sec id="s2_1">
<label>2.1</label>
<title>Plant material and antimicrobial property screening</title>
<p>A total of 72 plant specimens (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>), including <italic>C. oppositifolia</italic>, were collected from two locations in Himachal Pradesh, India: Solan (altitude 1350&#xa0;m, temperature 20-30&#xb0;C, humidity 55-68%) and Shimla (altitude 2202&#xa0;m, temperature 12-25&#xb0;C, humidity 62-80%). The specimens, comprising leaves, buds, flowers, and tubers, were identified and verified using the herbarium at Dr Y.S. Parmar University of Horticulture and Forestry, Nauni, Himachal Pradesh. The collected specimens were washed with water and surface-sterilized using 1% hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), followed by rinsing with autoclaved distilled water to remove any residual H<sub>2</sub>O<sub>2</sub>, as per an established protocol in our laboratory. The surface-sterilised plant material was then dried in an oven at 40&#xb0;C until completely desiccated. The dried material was ground into a fine powder using an electronic mixer grinder (<xref ref-type="bibr" rid="B34">Sharma and Mishra, 2019</xref>). Among the specimens, <italic>C. oppositifolia</italic> extract exhibited significantly higher antimicrobial activity, as shown in our published data. Phytochemical analysis of the extracts revealed the presence of various bioactive compounds, including phenols, terpenoids, flavonoids, tannins, coumarins, glycosides, and alkaloids. EOs were subsequently extracted from <italic>C. oppositifolia</italic> and further investigated for this study.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Extraction of essential oil</title>
<p>The EOs were extracted using an environmentally friendly hydro-distillation method (<xref ref-type="bibr" rid="B1">Abbas et&#xa0;al., 2022</xref>) and calculated by Extract Yield (%)= (Weight of starting material/Weight of extract obtained)&#xd7;100. Fresh leaves and inflorescence of <italic>C. oppositifolia</italic> were subjected to hydro-distillation using a Clevenger apparatus. Two hundred grams of chopped plant material were placed in a round-bottom flask, and 400 mL of distilled water was added. The mixture underwent hydro-distillation for 3 hours. Afterwards, the organic phase was dried over sodium sulphate, and filtered, and the solvent was evaporated to dryness. The volatile oil was then stored at 4&#xb0;C until analysis. This method combines extraction and steam distillation into a single process, which reduces trial time, saves solvents, simplifies equipment, and facilitates operation. While the extraction rate is relatively low, the essential oil obtained is of high purity. However, the process involves high temperatures, which may lead to the volatilization or oxidation of certain components in the EOs. The method primarily collects insoluble EOs, resulting in the loss of water-soluble components and, consequently, a lower extraction yield. The extracted oil is still a multi-component composite essential oil, making it challenging to achieve selective extraction and complete purity.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Extraction of terpenoids</title>
<p>The EOs were further processed to isolate terpenoids using TLC (<xref ref-type="bibr" rid="B20">Jiang et&#xa0;al., 2016</xref>). Initially, a small quantity of the essential oil was dissolved in a minimal amount of an extraction solvent, typically a mixture of hexane and ethyl acetate in a 7:3 ratio. This solution was then placed onto a pre-coated silica gel TLC plate, which had been activated by heating at 110&#xb0;C for 30 minutes. The TLC plate was placed in a development chamber containing a mobile phase of hexane and ethyl acetate (7:3 ratio), allowing the solvent front to rise to about 3/4th of the plate&#x2019;s height. After development, the TLC plate was removed from the chamber and air-dried. Visualization of the terpenoids was achieved by observing the plate under UV light at 254 nm and 365 nm, where terpenoids typically have fluorescence. For further visualization, the plate was sprayed with anisaldehyde-sulfuric acid reagent and heated at 110&#xb0;C for 10 minutes, revealing distinct colored bands corresponding to the terpenoids. The retention factor (Rf) values of these bands were calculated and compared with known standards to identify the specific terpenoids present in the essential oil &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene. The results were documented by photographing the TLC plates and noting the colors and Rf values of the terpenoid spots.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Antimicrobial and synergistic effect of &#x3b1;-pinene, &#x3b4;-carene, caryophyllene</title>
<sec id="s2_4_1">
<label>2.4.1</label>
<title>Antimicrobial susceptibility testing</title>
<p>The antimicrobial susceptibility of the terpenoids&#x2014;&#x3b1;-pinene, &#x3b4;-carene, and caryophyllene, was assessed using the disc diffusion method (<xref ref-type="bibr" rid="B16">Gupta et&#xa0;al., 2023</xref>). Each compound was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 0.75 mg/mL and stored in sterile centrifuge tubes at 4&#xb0;C to reduce volatilization. For the susceptibility tests, the stock solutions were further diluted to 0.25 mg/mL, with 0.25% DMSO serving as the control. Bacterial inoculation was standardized to a concentration of 0.5 McFarland (1.5&#xd7;10<sup>5</sup> CFU/mL) by spectrophotometric measurement at 625 nm, ensuring an optical density of 0.06. The terpenoids were tested against <italic>E. coli</italic> MTCC-739 and <italic>S. aureus</italic> ATCC-43300. Standard antibiotics, amoxicillin (30 &#xb5;g) and erythromycin (15 &#xb5;g) were included for comparison, both individually and in combination with each terpenoid. Mueller-Hinton agar plates were inoculated and incubated at 37&#xb0;C for 18-20 hours. Antimicrobial activity was evaluated by measuring the zone of inhibition around each disc. Compounds that exhibited significant antimicrobial activity were selected for further determination of MIC.</p>
</sec>
<sec id="s2_4_2">
<label>2.4.2</label>
<title>Minimum inhibitory concentration determination</title>
<p>MIC values were determined using the microdilution method (<xref ref-type="bibr" rid="B23">Kowalska-Krochmal and Dudek-Wicher, 2021</xref>), with concentrations of each terpenoid ranging from 0.25 to 0.002 mg/mL. Assays were conducted individually for each microorganism to prevent cross-interaction due to volatilization. All tests were performed in triplicate, and results were interpreted according to the CLSI-M100 guidelines (<xref ref-type="bibr" rid="B8">Clinical &amp; Laboratory Standards Institute, 1999</xref>).</p>
</sec>
<sec id="s2_4_3">
<label>2.4.3</label>
<title>Time-kill study</title>
<p>A 24-hour time-kill curve study was performed according to CLSI document M26-A guidelines (<xref ref-type="bibr" rid="B4">M26-A Methods for Determining Bactericidal Activi.pdf, 2024</xref>). The terpenoids were evaluated at MIC, 2xMIC, and 4xMIC concentrations, with a negative control consisting of Mueller-Hinton broth, 0.25% DMSO, and bacterial inoculum. Bacterial suspensions were prepared as previously described, and the samples were incubated at 35&#xb0;C for 24 hours. At intervals of 0, 2, 4, 8, 12, and 24 hours, 10 &#xb5;L of each sample was diluted in 990 &#xb5;L of 0.9% sterile saline, and 100 &#xb5;L of this dilution was plated onto Mueller-Hinton agar. Plates were incubated for 24 hours at 35&#xb0;C, after which colony-forming units (CFU) were manually counted. The counts were multiplied by 1000 to determine CFU/mL, and these values were transformed into a logarithmic scale to generate time-kill curves. A bactericidal effect was defined as a &#x2265; 3 log<sub>10</sub> reduction in CFU from the initial count.</p>
</sec>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>FTIR spectra of terpenoids and combination with antibiotics</title>
<p>FTIR spectroscopy was employed to investigate the molecular interactions between terpenoids (&#x3b1;-pinene, &#x3b4;-carene, and caryophyllene) and antibiotics-amoxicillin and erythromycin. Terpenoids and antibiotics were prepared in solution, and FTIR spectra were recorded over the range of 4000&#x2013;400 cm<sup>&#x2212;1</sup> using an ATR accessory for liquid samples and KBr pellets for solid samples. The spectra were analyzed for characteristic peaks and shifts to identify functional groups and potential interactions. Comparison of the spectra of individual terpenoids with their combinations with antibiotics revealed changes in peak positions or intensities, providing insights into molecular interactions and potential synergistic effects.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>UV spectrophotometer spectra of terpenoids and combinations with antibiotics</title>
<p>UV spectrophotometry was utilized to analyze the absorbance characteristics of terpenoids-&#x3b1;-pinene, &#x3b4;-carene, and caryophyllene and their combinations with antibiotics-amoxicillin and erythromycin. Solutions of each terpenoid and antibiotic were prepared at a concentration of 0.1 mg/mL in methanol or acetonitrile. Combined samples were also prepared by mixing equal volumes of the terpenoid and antibiotic solutions. Using a UV-visible spectrophotometer, spectra were recorded over the range of 200&#x2013;400 nm. The baseline spectrum of the solvent was first recorded to correct for any background absorbance. Each sample was then analyzed to identify characteristic absorbance peaks and any shifts or changes when terpenoids were combined with antibiotics. These changes provided insights into the interactions between the compounds and their potential synergistic effects.</p>
</sec>
<sec id="s2_7">
<label>2.8</label>
<title>Docking study of combinations of terpenoids with antibiotics</title>
<p>The chemical structures of the selected terpenoids &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene and antibiotics-erythromycin and amoxicillin were first retrieved from the PubChem database- <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/in.sdf">https://pubchem.ncbi.nlm.nih.gov/in.sdf</ext-link> format and converted to.pdb format using OpenBabel. These ligands were then subjected to energy minimization using the MMFF94 force field to obtain their most stable conformations, with protonation states adjusted and any missing hydrogens added.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<p>Of 71 plant <italic>C. oppositifolia</italic> extracts that showed interesting antimicrobial potential, further essential oil was extracted. The EO by hydro-distillation method yielded 1.2% by weight of the starting plant material. The purity of the extracted oil was measured at 95%, but the process led to the loss of approximately 10% of volatile components and the oxidation of some sensitive compounds. The oil primarily contained insoluble components, with a reduction of 15% in water-soluble substances. Despite these losses, the EO maintained a high degree of purity and was suitable for further analysis.</p>
<sec id="s3_1">
<label>3.1</label>
<title>Terpenoids and antibiotics</title>
<p>The TLC analysis of the EO from <italic>C. oppositifolia</italic> revealed the presence of several terpenoids, including monoterpenes- &#x3b1;-pinene, &#x3b4;-carene, and sesquiterpene-caryophyllene (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). These terpenoids were identified based on their characteristic retention factor (Rf) values compared to known standards. The terpenoids were tested in combination with two antibiotics, amoxicillin and erythromycin (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Thin Layer Chromatography (TLC) Analysis of Terpenoids from <italic>Cissampelos oppositifolia</italic> Extracts and Their Combination with Antibiotics.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1481656-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Antimicrobial susceptibility</title>
<p>The antimicrobial screening results for <italic>S. aureus</italic> ATCC-43300 and <italic>E. coli</italic> MTCC-739 demonstrated varying degrees of efficacy for the essential oil terpenoids and their combinations with antibiotics (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). For <italic>S. aureus</italic> ATCC-43300, erythromycin alone yielded a zone of inhibition of 7 &#xb1; 0.2&#xa0;mm. When tested individually, &#x3b1;-pinene also showed a zone of 7 &#xb1; 0.2&#xa0;mm, while &#x3b4;-carene and caryophyllene produced zones of 10 &#xb1; 0.2&#xa0;mm and 8 &#xb1; 0.2&#xa0;mm, respectively. The combination of terpenoids with erythromycin enhanced the inhibitory effect, with &#x3b1;-pinene + erythromycin producing a zone of 10 &#xb1; 0.2&#xa0;mm, &#x3b4;-carene + erythromycin showing the largest zone of 11 &#xb1; 0.2&#xa0;mm, and caryophyllene + erythromycin yielding 8 &#xb1; 0.2&#xa0;mm. Among these, &#x3b4;-carene exhibited the most significant synergistic effect with erythromycin against <italic>S. aureus</italic>. For E. coli MTCC-739, amoxicillin alone resulted in a zone of inhibition of 4 &#xb1; 0.2&#xa0;mm. The individual terpenoids showed improved activity, with &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene producing zones of 9 &#xb1; 0.2&#xa0;mm, 11 &#xb1; 0.2&#xa0;mm, and 7 &#xb1; 0.2&#xa0;mm, respectively. Combinations of terpenoids with amoxicillin led to further enhanced inhibition: &#x3b1;-pinene + amoxicillin resulted in a zone of 12 &#xb1; 0.2&#xa0;mm, &#x3b4;-carene + amoxicillin showed a zone of 11 &#xb1; 0.2&#xa0;mm, and caryophyllene + amoxicillin achieved 8 &#xb1; 0.2&#xa0;mm. The combination of &#x3b1;-pinene with amoxicillin exhibited the most significant synergistic effect against <italic>E. coli</italic>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Antimicrobial activity of terpenoids alone and in combination with antibiotics against <italic>Staphylococcus aureus</italic> ATCC-43300 and <italic>Escherichia coli</italic> MTCC-739.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Antibiotic/Terpenoid</th>
<th valign="middle" align="center">
<italic>Staphylococcus aureus</italic> ATCC-43300</th>
<th valign="middle" align="center">
<italic>Escherichia coli</italic> MTCC-739</th>
</tr>
<tr>
<th valign="middle" align="left"/>
<th valign="middle" align="left">Zone of Inhibition (mm)</th>
<th valign="middle" align="left">Zone of Inhibition (mm)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Erythromycin</td>
<td valign="middle" align="left">7 &#xb1; 0.2</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3b1;-Pinene</td>
<td valign="middle" align="left">7 &#xb1; 0.2</td>
<td valign="middle" align="left">9 &#xb1; 0.2</td>
</tr>
<tr>
<td valign="middle" align="left">Carene</td>
<td valign="middle" align="left">10 &#xb1; 0.2</td>
<td valign="middle" align="left">11 &#xb1; 0.2</td>
</tr>
<tr>
<td valign="middle" align="left">Caryophyllene</td>
<td valign="middle" align="left">8 &#xb1; 0.2</td>
<td valign="middle" align="left">7 &#xb1; 0.2</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3b1;-Pinene + Erythromycin</td>
<td valign="middle" align="left">10 &#xb1; 0.2</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3b4;-carene + Erythromycin</td>
<td valign="middle" align="left">11 &#xb1; 0.2</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="left">Caryophyllene + Erythromycin</td>
<td valign="middle" align="left">8 &#xb1; 0.2</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="left">Amoxicillin</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">10&#xb1; 0.2</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3b1;-Pinene + Amoxicillin</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">12 &#xb1; 0.2</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3b4;-carene + Amoxicillin</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">11 &#xb1; 0.2</td>
</tr>
<tr>
<td valign="middle" align="left">Caryophyllene + Amoxicillin</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">8 &#xb1; 0.2</td>
</tr>
<tr>
<td valign="middle" align="left">Best Synergistic Effect with Erythromycin</td>
<td valign="middle" align="left">&#x3b4;-carene + Erythromycin</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="left">Best Synergistic Effect with Amoxicillin</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">- &#x3b1;-Pinene + Amoxicillin</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s3_2_1">
<label>3.2.1</label>
<title>MICs of terpenoids</title>
<p>MICs of the compounds were evaluated for both <italic>S. aureus</italic> ATCC-43300 and <italic>E. coli</italic> MTCC-739. The results are presented in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>. &#x3b1;-Pinene exhibited a MIC of 0.08 mg/mL against S. aureus ATCC-43300 and 0.06 mg/mL against E. coli MTCC-739, indicating a moderate inhibitory effect. &#x3b4;-carene showed the lowest MIC values, with 0.04 mg/mL for <italic>S. aureus</italic> ATCC-43300 and 0.05 mg/mL for <italic>E. coli</italic> MTCC-739, suggesting a stronger antimicrobial activity compared to the other compounds. Caryophyllene had MICs of 0.07 mg/mL against <italic>S. aureus</italic> ATCC-43300 and 0.08 mg/mL against <italic>E. coli</italic> MTCC-739, reflecting its effective but slightly less potent activity. Erythromycin had an MIC of 0.5 mg/mL against <italic>S. aureus</italic> ATCC-43300, while amoxicillin showed an MIC of 0.5 mg/mL against <italic>E. coli</italic> MTCC-739. These results highlight the varying levels of effectiveness of the terpenoids and antibiotics against the tested bacterial strains.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Minimum Inhibitory Concentrations (mg/mL) of the terpenoids.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Compound</th>
<th valign="middle" align="center">
<italic>S. aureus</italic> ATCC-43300</th>
<th valign="middle" align="center">
<italic>E. coli</italic> MTCC-739</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">&#x3b1;-Pinene</td>
<td valign="middle" align="center">0.08</td>
<td valign="middle" align="center">0.06</td>
</tr>
<tr>
<td valign="middle" align="left">Carene</td>
<td valign="middle" align="center">0.04</td>
<td valign="middle" align="center">0.05</td>
</tr>
<tr>
<td valign="middle" align="left">Caryophyllene</td>
<td valign="middle" align="center">0.07</td>
<td valign="middle" align="center">0.08</td>
</tr>
<tr>
<td valign="middle" align="left">Erythromycin</td>
<td valign="middle" align="center">0.5</td>
<td valign="middle" align="center">N/A</td>
</tr>
<tr>
<td valign="middle" align="left">Amoxicillin</td>
<td valign="middle" align="center">N/A</td>
<td valign="middle" align="center">0.5</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_2_2">
<label>3.2.2</label>
<title>Time killing</title>
<p>he time-kill assay was conducted to assess the antimicrobial efficacy of &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene against <italic>E. coli</italic> MTCC-739 and <italic>S. aureus</italic> ATCC-43300, both individually and in combination with amoxicillin or erythromycin (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). All treatments began with an initial bacterial load of 5 log<sub>10</sub> CFU/ml at time zero. In the case of <italic>E. coli</italic>, during the first hour, &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene alone showed varying antibacterial activity, with bacterial counts reducing to 4, 0, and 6 log<sub>10</sub> CFU/ml, respectively. Amoxicillin alone did not reduce the bacterial load at this early stage. By the second hour, &#x3b1;-Pinene and &#x3b4;-carene maintained complete bacterial killing (0 log<sub>10</sub> CFU/ml), while caryophyllene remained less effective, with a count of 6 log<sub>10</sub> CFU/ml. Amoxicillin alone continued to show no reduction. By the four-hour mark, all treatments, including the combinations of &#x3b1;-pinene + amoxicillin, &#x3b4;-carene + amoxicillin, and caryophyllene + amoxicillin, achieved a complete bacterial kill, maintaining a 0 log<sub>10</sub> CFU/ml count. This bactericidal effect persisted through 8, 12, and 24 hours, indicating the potent efficacy of these compounds, particularly when combined with amoxicillin. A similar pattern was observed in <italic>S. aureus</italic> ATCC-43300. After 1 hour, &#x3b1;-Pinene and &#x3b4;-carene alone reduced the bacterial load to 4 log<sub>10</sub> CFU/ml, while caryophyllene alone led to an increase in the bacterial count to 6 log<sub>10</sub> CFU/ml. Erythromycin alone showed no significant reduction, but the combinations of &#x3b1;-pinene + erythromycin and &#x3b4;-carene + erythromycin completely eradicated the bacteria, achieving 0 log<sub>10</sub> CFU/ml. By the second hour, &#x3b1;-Pinene alone eliminated <italic>S. aureus</italic>, while &#x3b4;-carene reduced the count to 2 log<sub>10</sub> CFU/ml. Caryophyllene remained ineffective with 6 log<sub>10</sub> CFU/ml, and erythromycin alone was still ineffective. At the four-hour mark, all treatments, except caryophyllene and erythromycin alone, achieved complete bacterial killing. This trend continued through 8, 12, and 24 hours, with &#x3b1;-pinene, &#x3b4;-carene, and their combinations with erythromycin effectively maintaining a 0 log<sub>10</sub> CFU/ml count. In contrast, caryophyllene and erythromycin alone exhibited limited antibacterial activity, with caryophyllene showing no reduction and erythromycin gradually reducing the bacterial load to 4 log<sub>10</sub> CFU/ml by 24 hours. These results demonstrate that &#x3b1;-pinene, &#x3b4;-carene, and their combinations with either amoxicillin or erythromycin exhibit strong bactericidal activity against both <italic>E. coli a</italic>nd <italic>S. aureus</italic>. To further validate these primary results, it is essential to investigate the mode of action of each terpenoid&#x2014;&#x3b1;-pinene, &#x3b4;-carene, and caryophyllene&#x2014;by studying their effects on bacterial cell wall integrity. This can be done through assays designed to assess cell wall disruption, which would provide insights into the bactericidal mechanisms of these compounds. By evaluating how these terpenoids interact with bacterial cell walls, we can better understand whether their antimicrobial efficacy stems from cell wall destruction.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Time-Kill Assay of Terpenoids and Their Combinations with Antibiotics Against <italic>E</italic>. <italic>coli</italic> MTCC-739 <bold>(A)</bold> and <italic>S. aureus</italic> ATCC-43300 <bold>(B)</bold>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1481656-g002.tif"/>
</fig>
</sec>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>FTIR spectroscopy</title>
<p>The FTIR spectra analysis of antibiotics and terpenoids (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>) revealed significant modifications in the functional groups when combined, suggesting potential synergistic interactions. The overlay spectra for the combinations were analyzed. For the amoxicillin + &#x3b1;-Pinene combination, distinct peak shifts were observed at 1599, 1774, and 2259 cm<sup>&#x2212;1</sup> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Similarly, the combination of &#x3b1;-Pinene with Amoxicillin showed a peak shift at 1715 cm<sup>&#x2212;1</sup> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). The combination of amoxicillin with caryophyllene exhibited peak shifts at 1599 and 1774 cm<sup>&#x2212;1</sup> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Notably, the overlay of caryophyllene with amoxicillin resulted in similar peak modifications as seen with carene, at 1599 and 1774 cm<sup>&#x2212;1</sup> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). In contrast, the combination of &#x3b4;-carene with erythromycin generated new peaks at 1648 and 1287 cm<sup>&#x2212;1</sup>, indicating a different interaction pattern (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). Furthermore, the overlay of caryophyllene with amoxicillin led to the disappearance of the amoxicillin peaks at 1599 and 1774 cm<sup>&#x2212;1</sup>, while no modifications were observed in the caryophyllene and erythromycin combination (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). These spectral changes suggest that the combination of terpenoids with antibiotics results in functional group modifications, which could be responsible for the observed synergistic effects in antimicrobial activity.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>FTIR Spectroscopy Analysis of Functional Group Modifications in Terpenoid-Antibiotic Combinations. <bold>(A)</bold> Amoxicillin + &#x3b1;-Pinene; <bold>(B)</bold> Erythromycin + &#x3b1;-Pinene; <bold>(C)</bold> Amoxicillin + &#x3b4;-Carene <bold>(D)</bold> Amoxicillin + Caryophyllene <bold>(E)</bold> Erythromycin + &#x3b4;-Carene <bold>(F)</bold> Erythromycin + Caryophyllene.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1481656-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>UV spectrophotometer</title>
<p>Notable changes in the UV spectra were observed when terpenoids were mixed with antibiotics, suggesting possible interactions or alterations in the molecular structure of the components. In the combination of amoxicillin with &#x3b1;-Pinene (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>), significant shifts in the absorption peaks were noted, indicating potential interactions that may alter the electronic environment of the molecules. These shifts could be indicative of changes in the conjugation of the antibiotic&#x2019;s chromophore when combined with the terpenoid. Similarly, the combination of erythromycin with &#x3b1;-Pinene (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>) also showed noticeable peak shifts, further supporting the possibility of complex formation between these molecules. When amoxicillin was combined with &#x3b4;-carene (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>), distinct modifications in the absorption spectra were observed, highlighting potential changes in the molecular interactions. Caryophyllene, when mixed with amoxicillin (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>), showed similar alterations in the UV spectra, suggesting that the interaction between these molecules may involve modifications in their electronic structures. The combination of &#x3b4;-carene and erythromycin (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>) revealed the formation of new absorption peaks, indicating the possible creation of new molecular entities or complexes. Finally, the spectra for caryophyllene and erythromycin (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>) showed minimal modifications, suggesting that while interactions may occur, they might be less pronounced than with other combinations. Overall, these results suggest that the mixing of terpenoids and antibiotics leads to changes in their UV absorption spectra, which could indicate complex formation or alterations in their molecular structures. These findings provide valuable insights into the potential synergistic effects observed in combination therapies involving these compounds.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>UV Spectrophotometry Analysis of Terpenoid-Antibiotic Interactions. <bold>(A)</bold> Amoxicillin + &#x3b1;-Pinene; <bold>(B)</bold> Erythromycin + &#x3b1;-Pinene; <bold>(C)</bold> UV Spectrum of Amoxicillin + &#x3b4;-Carene; <bold>(D)</bold> Amoxicillin + Caryophyllene; <bold>(E)</bold> UV Spectrum of Erythromycin + &#x3b4;-Carene; <bold>(F)</bold> Erythromycin + Caryophyllene.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1481656-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Docking interactions of terpenoids with antibiotics</title>
<p>The docking results suggested the interaction energy values were analyzed to determine the strength of the interactions. Lower (more negative) values of interaction energy indicate stronger interactions. The docking structure for terpenoids- &#x3b1;-pinene, &#x3b4;-carene and antibiotics- erythromycin, amoxicillin adopted, we have not included caryophyllene for the docking study (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2</bold>
</xref>). The highest interaction was observed between &#x3b4;-carene and erythromycin, with a total interaction energy value of -96.10 kcal/mol, suggesting a strong binding affinity between these two compounds (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). This was followed by &#x3b4;-carene with amoxicillin, which had an interaction energy value of -87.75 kcal/mol, indicating a significant interaction as well (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). The &#x3b1;-pinene with erythromycin demonstrated an interaction energy of -83.58 kcal/mol, also reflecting a strong interaction but with amoxicillin had a slightly lower interaction energy value of -74.26 kcal/mol (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5C, D</bold>
</xref>). Lastly, the combination of &#x3b1;-pinene with &#x3b4;-carene displayed an interaction energy of -57.02 kcal/mol, which, although lower compared to the other pairs (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>). These docking results suggest that &#x3b4;-carene exhibits the highest potential for interaction with both erythromycin and amoxicillin, which could imply enhanced efficacy or synergistic effects in therapeutic applications involving these combinations.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Docking Interactions of Terpenoids with Antibiotics Showing the Top Five Binding Conformations. <bold>(A)</bold> &#x3b4;-Carene with Erythromycin; <bold>(B)</bold> Amoxicillin; <bold>(C)</bold> Docking of &#x3b1;-Pinene with Erythromycin; <bold>(D)</bold> &#x3b1;-Pinene with Amoxicillin <bold>(E)</bold> Docking of &#x3b1;-Pinene with &#x3b4;-Carene.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1481656-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>The study explores the antimicrobial potential of <italic>C. oppositifolia</italic> EOs and its terpenoid constituents, such as &#x3b1;-pinene, &#x3b4;-carene, and caryophyllene, in combination with antibiotics like amoxicillin and erythromycin. The findings offer significant insights into their individual and synergistic effects against <italic>S. aureus</italic> and <italic>E. coli</italic>, contributing to our understanding of their potential applications in combating bacterial infections. The essential oil extracted from <italic>C. oppositifolia</italic> yielded 1.2% of the starting plant material, with a high purity of 95%. This extraction efficiency and purity are comparable to other studies on essential oils, which often report similar yields and purities, although minor losses due to volatility and oxidation were noted (<xref ref-type="bibr" rid="B33">Sharma et&#xa0;al., 2021</xref>). Despite these losses, the EO&#x2019;s integrity and suitability for further analysis were maintained. The TLC analysis confirmed the presence of key terpenoids&#x2014;&#x3b1;-pinene, &#x3b4;-carene, and caryophyllene&#x2014;in the EO. These findings are consistent with previous research identifying these terpenoids in <italic>C. oppositifolia</italic> and other plant species (<xref ref-type="bibr" rid="B6">Basholli-Salihu et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B17">Hanu&#x161; and Hod, 2020</xref>). The individual antimicrobial activity of these terpenoids demonstrated varying efficacy, with &#x3b4;-carene showing the most potent effect against both <italic>S. aureus</italic> and <italic>E. coli</italic>. This is in line with other studies reporting &#x3b4;-carene&#x2019;s significant antimicrobial properties (<xref ref-type="bibr" rid="B35">Swamy et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B15">Guimar&#xe3;es et&#xa0;al., 2019</xref>). When combined with antibiotics, the terpenoids exhibited synergistic effects. For <italic>S. aureus</italic>, the combination of &#x3b4;-carene and erythromycin resulted in the largest zone of inhibition, aligning with the findings of synergistic effects between terpenoids and antibiotics observed in similar studies (<xref ref-type="bibr" rid="B24">Mahfouz et&#xa0;al., 2023</xref>). Similarly, the combination of &#x3b1;-pinene with amoxicillin showed enhanced inhibition against <italic>E. coli</italic>, highlighting the potential for these combinations to improve therapeutic efficacy. The MIC values revealed that &#x3b4;-carene had the lowest MICs for both bacterial strains, indicating its superior antimicrobial activity. These results are consistent with other studies that have reported &#x3b4;-carene as a potent antimicrobial agent (<xref ref-type="bibr" rid="B29">Roman et&#xa0;al., 2023</xref>). Caryophyllene and &#x3b1;-pinene also demonstrated effective antimicrobial properties, although with higher MIC values compared to &#x3b4;-carene (<xref ref-type="bibr" rid="B36">Valdivieso-Ugarte et&#xa0;al., 2019</xref>). The time-kill assay provided a detailed understanding of the bactericidal effects of the terpenoids and their combinations. All tested compounds, both individually and in combination with antibiotics, were effective in achieving complete bacterial kill at various time points. This is particularly noteworthy for the combination of &#x3b1;-pinene, &#x3b4;-carene, and amoxicillin, which showed sustained bactericidal activity. Similar trends have been observed in other studies evaluating the time-kill kinetics of terpenoids and antibiotics (<xref ref-type="bibr" rid="B10">da Silva Rivas et&#xa0;al., 2012</xref>). The FTIR and UV spectroscopy analyses revealed significant changes in the functional groups and absorption spectra of the terpenoid-antibiotic combinations. The observed peak shifts and modifications suggest potential interactions or complex formations between these molecules. These findings are supported by other studies that have used FTIR and UV spectroscopy to investigate the interactions between terpenoids and antibiotics (<xref ref-type="bibr" rid="B19">Huang et&#xa0;al., 2022</xref>). The presence of new peaks or disappearance of existing ones in the spectra indicates possible changes in the molecular structures or electronic environments, which could contribute to the observed synergistic effects. Docking studies further elucidated the interaction energies between terpenoids and antibiotics. The strongest interactions were observed between &#x3b4;-carene and erythromycin, with an interaction energy of -96.10 kcal/mol. This suggests a high binding affinity and potential for enhanced therapeutic efficacy. The results align with other docking studies that have explored similar interactions (<xref ref-type="bibr" rid="B37">Zlotnikov et&#xa0;al., 2023</xref>). Several limitations should be considered in interpreting these results. First, while the study provides valuable insights into the antimicrobial potential and interactions of the terpenoids and antibiotics, the <italic>in- vitro</italic> nature of the assays may not fully represent the <italic>in-vivo</italic> conditions. The effects observed in laboratory settings may differ from those in a physiological context due to factors such as metabolism and bioavailability. Study focused on a limited number of terpenoids and antibiotics. The inclusion of additional compounds could provide a more comprehensive understanding of potential synergistic effects and interactions. Study did not explore the mechanisms of action of the terpenoids and antibiotics in detail. Additional research, such as assessing bacterial cell wall integrity and intracellular targets, would provide deeper insights into how these compounds exert their antimicrobial effects. FTIR and UV spectroscopy analyses suggest possible interactions, further structural characterization and validation using techniques like NMR and X-ray crystallography could provide more definitive evidence of complex formation and interaction mechanisms.</p>
</sec>
<sec id="s5" sec-type="conclusion">
<label>5</label>
<title>Conclusion</title>
<p>The study demonstrates the significant antimicrobial potential of <italic>C. oppositifolia</italic> terpenoids and their synergistic effects with antibiotics. The results highlight the potential for developing novel combination therapies to enhance antimicrobial efficacy. However, further research is needed to validate these findings <italic>in vivo</italic>, explore additional terpenoid and antibiotic combinations, and elucidate the detailed mechanisms of action.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>KZ: Formal analysis, Methodology, Resources, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. YJ: Conceptualization, Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. KD: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. XH: Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. VS: Conceptualization, Investigation, Methodology, Project administration, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. XP: Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2024.1481656/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2024.1481656/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Anwar</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Alqahtani</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Ahmad</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Al-Mijalli</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Shahid</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Hydro-distilled and supercritical fluid extraction of eucalyptus camaldulensis essential oil: characterization of bioactives along with antioxidant, antimicrobial and antibiofilm activities</article-title>. <source>Dose Response</source> <volume>20</volume>, <elocation-id>15593258221125477</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/15593258221125477</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Habib</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nazir</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Haque</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Healthcare challenges in LMICs: addressing antibiotic resistance threats, a call for comprehensive global solutions: an editorial</article-title>. <source>Int. J. Surg.</source> <volume>110</volume>, <fpage>3085</fpage>&#x2013;<lpage>3087</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/JS9.0000000000001165</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>Antimicrobial Resistance Collaborators</collab>
</person-group>. (<year>2022</year>). <article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>Lancet</source> <volume>399</volume>, <fpage>629</fpage>&#x2013;<lpage>655</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="web">
<source>M26-A Methods for Determining Bactericidal Activi.pdf</source>. (<year>2024</year>) Available online at: <uri xlink:href="https://clsi.org/media/1462/m26a_sample.pdf">https://clsi.org/media/1462/m26a_sample.pdf</uri> (Accessed <access-date>August 14, 2024</access-date>).</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Mahmud</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>I. F.</given-names>
</name>
<name>
<surname>Rajeev</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Rasambainarivo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Rice</surname> <given-names>B. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Infectious disease in an era of global change</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>20</volume>, <fpage>193</fpage>&#x2013;<lpage>205</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-021-00639-z</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basholli-Salihu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schuster</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hajdari</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mulla</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Viernstein</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Mustafa</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Phytochemical composition, anti-inflammatory activity and cytotoxic effects of essential oils from three Pinus spp</article-title>. <source>Pharm. Biol</source>. <volume>55</volume> (<issue>1</issue>), <fpage>1553</fpage>&#x2013;<lpage>1560</lpage> doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13880209.2017.1309555</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaachouay</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Zidane</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Plant-derived natural products: A source for drug discovery and development</article-title>. <source>Drugs Drug Candidates</source> <volume>3</volume>, <fpage>184</fpage>&#x2013;<lpage>207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ddc3010011</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>Clinical &amp; Laboratory Standards Institute</collab>
</person-group>. (<year>1999</year>). <source>CLSI Guidelines</source>. Available online at: <uri xlink:href="https://clsi.org/">https://clsi.org/</uri> (Accessed <access-date>March 28, 2024</access-date>).</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cowan</surname> <given-names>M. M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Plant products as antimicrobial agents</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>12</volume>, <fpage>564</fpage>&#x2013;<lpage>582</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.12.4.564</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva Rivas</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>de Azevedo Barros</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Costa MaChado</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Alviano</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Alviano</surname> <given-names>D. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Biological activities of &#x3b1;-pinene and &#x3b2;-pinene enantiomers</article-title>. <source>Molecules</source> <volume>17</volume>, <fpage>6305</fpage>&#x2013;<lpage>6316</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules17066305</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Kraker</surname> <given-names>M. E. A.</given-names>
</name>
<name>
<surname>Stewardson</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Harbarth</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Will 10 million people die a year due to antimicrobial resistance by 2050</article-title>? <source>PloS Med.</source> <volume>13</volume>, <elocation-id>e1002184</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pmed.1002184</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Sousa</surname> <given-names>D. P.</given-names>
</name>
<name>
<surname>Damasceno</surname> <given-names>R. O. S.</given-names>
</name>
<name>
<surname>Amorati</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Elshabrawy</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>de Castro</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Bezerra</surname> <given-names>D. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Essential oils: chemistry and pharmacological activities</article-title>. <source>Biomolecules</source> <volume>13</volume>, <elocation-id>1144</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom13071144</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhifi</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Bellili</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jazi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bahloul</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Mnif</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Essential oils&#x2019; Chemical characterization and investigation of some biological activities: A critical review</article-title>. <source>Medicines</source> <volume>3</volume>, <elocation-id>25</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/medicines3040025</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gersbach</surname> <given-names>P. V.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The essential oil secretory structures of prostanthera ovalifolia (Lamiaceae)</article-title>. <source>Ann. Bot.</source> <volume>89</volume>, <fpage>255</fpage>&#x2013;<lpage>260</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/aob/mcf033</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guimar&#xe3;es</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Meireles</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Lemos</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Guimar&#xe3;es</surname> <given-names>M. C. C.</given-names>
</name>
<name>
<surname>Endringer</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Fronza</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Antibacterial activity of terpenes and terpenoids present in essential oils</article-title>. <source>Molecules</source> <volume>24</volume>, <elocation-id>2471</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules24132471</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Urbanov&#xe1;</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Dutta</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hazra</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Cusimamani</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Systematic analysis of antimicrobial activity, phytochemistry, and in silico molecular interaction of selected essential oils and their formulations from different Indian spices against foodborne bacteria</article-title>. <source>Heliyon</source> <volume>9</volume>, <elocation-id>e22480</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e22480</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanu&#x161;</surname> <given-names>L. O.</given-names>
</name>
<name>
<surname>Hod</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Terpenes/terpenoids in cannabis: are they important</article-title>? <source>Med. Cannabis Cannabinoids</source> <volume>3</volume>, <fpage>25</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000509733</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haro-Gonz&#xe1;lez</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Castillo-Herrera</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Vel&#xe1;zquez</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Espinosa-Andrews</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Clove essential oil (Syzygium aromaticum L. Myrtaceae): extraction, chemical composition, food applications, and essential bioactivity for human health</article-title>. <source>Molecules</source> <volume>26</volume>, <elocation-id>6387</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26216387</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Biosynthesis investigations of terpenoid, alkaloid, and flavonoid antimicrobial agents derived from medicinal plants</article-title>. <source>Antibiotics</source> <volume>11</volume>, <elocation-id>1380</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antibiotics11101380</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Kempinski</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Chappell</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Extraction and analysis of terpenes/terpenoids</article-title>. <source>Curr. Protoc. Plant Biol.</source> <volume>1</volume>, <fpage>345</fpage>&#x2013;<lpage>358</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cppb.20024</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jugreet</surname> <given-names>S. B.</given-names>
</name>
<name>
<surname>Suroowan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Rengasamy</surname> <given-names>R. R. K.</given-names>
</name>
<name>
<surname>Mahomoodally</surname> <given-names>M. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Chemistry, bioactivities, mode of action and industrial applications of essential oils</article-title>. <source>Trends Food Sci. Technol.</source> <volume>101</volume>, <fpage>89</fpage>&#x2013;<lpage>105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tifs.2020.04.025</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konwar</surname> <given-names>A. N.</given-names>
</name>
<name>
<surname>Hazarika</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Bharadwaj</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Thakur</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Emerging non-traditional approaches to combat antibiotic resistance</article-title>. <source>Curr. Microbiol.</source> <volume>79</volume>, <fpage>330</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00284-022-03029-7</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowalska-Krochmal</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dudek-Wicher</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance</article-title>. <source>Pathogens</source> <volume>10</volume>, <elocation-id>165</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens10020165</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahfouz</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Said</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Elfeky</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Shaaban</surname> <given-names>M. I.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates</article-title>. <source>Antibiotics (Basel)</source> <volume>12</volume>, <elocation-id>503</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antibiotics12030503</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahizan</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S.-K.</given-names>
</name>
<name>
<surname>Moo</surname> <given-names>C.-L.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>A. A.-L.</given-names>
</name>
<name>
<surname>Chong</surname> <given-names>C.-M.</given-names>
</name>
<name>
<surname>Chong</surname> <given-names>C.-W.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Terpene derivatives as a potential agent against antimicrobial resistance (AMR) pathogens</article-title>. <source>Molecules</source> <volume>24</volume>, <elocation-id>2631</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules24142631</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masyita</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mustika Sari</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Dwi Astuti</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Yasir</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Rahma Rumata</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Emran</surname> <given-names>T. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives</article-title>. <source>Food Chem. X</source> <volume>13</volume>, <elocation-id>100217</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fochx.2022.100217</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasim</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Sandeep</surname> <given-names>I. S.</given-names>
</name>
<name>
<surname>Mohanty</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Plant-derived natural products for drug discovery: current approaches and prospects</article-title>. <source>Nucleus (Calcutta)</source> <volume>65</volume>, <fpage>399</fpage>&#x2013;<lpage>411</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13237-022-00405-3</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proshkina</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Plyusnin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Babak</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Lashmanova</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Maganova</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Koval</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Terpenoids as potential geroprotectors</article-title>. <source>Antioxidants</source> <volume>9</volume>, <elocation-id>529</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox9060529</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roman</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Voaides</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Babeanu</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Exploring the sustainable exploitation of bioactive compounds in pelargonium sp.: beyond a fragrant plant</article-title>. <source>Plants</source> <volume>12</volume>, <elocation-id>4123</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/plants12244123</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salam</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Al-Amin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Salam</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Pawar</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Akhter</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Rabaan</surname> <given-names>A. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Antimicrobial resistance: A growing serious threat for global public health</article-title>. <source>Healthcare (Basel)</source> <volume>11</volume>, <elocation-id>1946</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/healthcare11131946</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Gandass</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kajal</surname>
</name>
<name>
<surname>Verma</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rajarammohan</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Antimicrobial potential of essential oils from aromatic plant ocimum sp.; A comparative biochemical profiling and in-silico analysis</article-title>. <source>Agronomy</source> <volume>12</volume>, <elocation-id>627</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/agronomy12030627</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dev</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Patil</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Phytochemical characterization and synergistic antibacterial effects of colebrookea oppositifolia essential oil as adjuvants to modern antibiotics in combating drug resistance</article-title>. <source>DDDT</source> <volume>18</volume>, <fpage>4601</fpage>&#x2013;<lpage>4614</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/DDDT.S489517</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Khajuria</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lone</surname> <given-names>N. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Dereplication based strategy for rapid identification and isolation of a novel anti-inflammatory flavonoid by LCMS/MS from colebrookea oppositifolia</article-title>. <source>ACS Omega</source> <volume>6</volume>, <fpage>30241</fpage>&#x2013;<lpage>30259</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acsomega.1c01837</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Phytochemical analysis, high-performance liquid chromatography, and ex vivo antioxidant potential of A herbal fruit extract</article-title>. <source>Asian J. Pharm. Clin. Res.</source>, <fpage>256</fpage>&#x2013;<lpage>260</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.22159/ajpcr.2019.v12i2.29760</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swamy</surname> <given-names>M. K.</given-names>
</name>
<name>
<surname>Akhtar</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Sinniah</surname> <given-names>U. R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review</article-title>. <source>Evid Based Complement Alternat Med.</source> <volume>2016</volume>, <elocation-id>3012462</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/3012462</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdivieso-Ugarte</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gomez-Llorente</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Plaza-D&#xed;az</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gil</surname> <given-names>&#xc1;.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Antimicrobial, antioxidant, and immunomodulatory properties of essential oils: A systematic review</article-title>. <source>Nutrients</source> <volume>11</volume>, <elocation-id>2786</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu11112786</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zlotnikov</surname> <given-names>I. D.</given-names>
</name>
<name>
<surname>Davydova</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Danilov</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Krylov</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Belogurova</surname> <given-names>N. G.</given-names>
</name>
<name>
<surname>Kudryashova</surname> <given-names>E. V.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Covalent conjugates of allylbenzenes and terpenoids as antibiotics enhancers with the function of prolonged action</article-title>. <source>Pharmaceuticals</source> <volume>16</volume>, <elocation-id>1102</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ph16081102</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>